Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kwok Kong Loh"'
Autor:
Hee Hwa Ho, Dasdo Antonius Sinaga, Mohd Kamal Mohd Arshad, Sazzli Kasim, Jin Hyun Lee, Deanna Zhi Lin Khoo, Kwok Kong Loh, Fahim Haider Jafary, Paul Jau Lueng Ong, Simon Soo Siong Lo
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss , Pp - (2020)
Background: Amphilimus-eluting stent (AES) is a novel polymer-free drug eluting stent that combines sirolimus with fatty acid as antiproliferative drug and has shown promising results in percutaneous coronary intervention.We evaluated the clinical sa
Externí odkaz:
https://doaj.org/article/6af6a29cd7a047de898e27c5c5203730
Autor:
Wen Jun Sim, An Shing Ang, Mae Chyi Tan, Wen Wei Xiang, David Foo, Kwok Kong Loh, Fahim Haider Jafary, Timothy James Watson, Paul Jau Lueng Ong, Hee Hwa Ho
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185186 (2017)
To evaluate causes and impact of delay in the door-to-balloon (D2B) time for patients undergoing primary percutaneous coronary intervention (PPCI).From January 2009 to December 2012, 1268 patients (86% male, mean age of 58 ± 12 years) presented to o
Externí odkaz:
https://doaj.org/article/5acdbe7fa7304d58893dbde2fe4352aa
Autor:
Hee Hwa Ho, Ki Fung Cliff Li, Jun Bang Low, Thet Khaing, Jinhyun Lee, Deanna Zin Lin Khoo, Jason Kwok Kong Loh, Fahim Haider Jafary
Publikováno v:
Journal of the American College of Cardiology. 79:S7
Autor:
Simon Soo Siong Lo, Fahim Haider Jafary, Hee Hwa Ho, Dasdo Antonius Sinaga, Paul Jau Lueng Ong, Mohd Kamal Mohd Arshad, Jin Hyun Lee, Sazzli Kasim, Kwok Kong Loh, Deanna Zhi Lin Khoo
Publikováno v:
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss, Pp-(2020)
International Journal of Cardiology: Heart & Vasculature, Vol 26, Iss, Pp-(2020)
Background: Amphilimus-eluting stent (AES) is a novel polymer-free drug eluting stent that combines sirolimus with fatty acid as antiproliferative drug and has shown promising results in percutaneous coronary intervention.We evaluated the clinical sa
Autor:
Timothy James Watson, Jason Kwok Kong Loh, D. J. H. Lee, F. H. Jafary, Paul Jl. Ong, H.-P. Stoll, Hee Hwa Ho
Publikováno v:
Herz. 44:750-755
The polymer-free biolimus-A9 drug-coated stent (DCS) was reported to have superior safety and efficacy outcomes compared with a bare metal stent in the LEADERS FREE trial of high-bleeding-risk patients with acute coronary syndrome and on dual antipla
Autor:
Kwee Keng Kng, Jason Kwok Kong Loh, Sze Mian Lim, Alexandre Chan, Joyce Yu-Chia Lee, She Hui Tan
Publikováno v:
Clinical Therapeutics. 39:2355-2365
Purpose Few studies have determined the benefits of pharmacist-run clinics within a tertiary institution, and specifically on their capability to improve clinical outcomes as well as reduce the cost of illness. This study was designed to investigate
Autor:
Thuzar Tint Nyein, Fahim Haider Jafary, Dasdo Antonius Sinaga, Jason Kwok Kong Loh, Alyssa Sim, Hee Hwa Ho, Timothy James Watson, Paul Jau Lueng Ong, Yau Wei Ooi, Julian K.B. Tan
Publikováno v:
Journal of Interventional Cardiology. 29:454-460
Background Drug-coated balloons (DCB) have been used to treat de novo small vessel coronary disease (SVD), with promising results and shorter dual antiplatelet therapy (DAPT) duration compared to drug-eluting stents (DES). We compared safety and effe
Autor:
Paul Jl. Ong, Fahim Haider Jafary, Z L Tin, Jason Kwok Kong Loh, T. Watson, Hee Hwa Ho, Mohd Kamal Mohd Arshad, C K Tan
Publikováno v:
Herz. 44(5)
Lesion length is a major predictor of adverse outcomes after percutaneous coronary intervention. Long lesions often require multiple stents with variable overlap, which increases the probability of geographical miss and the incidence of mechanical co
Autor:
Dasdo Antonius Sinaga, Timothy James Watson, Mohd Kamal Mohd Arshad, Fahim Haider Jafary, Paul Jl. Ong, Deanna Zhi-Lin Khoo, Hee Hwa Ho, Sazzli Kasim, Jason Kwok Kong Loh, Simon Soo Siong Lo
Publikováno v:
Journal of the American College of Cardiology. 71:S57-S58
Amphilimus-eluting stent (AES) is a novel polymer-free drug-eluting stent (DES) that combines sirolimus with fatty acid as anti-proliferative drug and has shown promising results in the percutaneous coronary intervention (PCI). There is limited data
Autor:
Paul Jau Lueng Ong, Deanna Zhi-Lin Khoo, Jin Hyun Lee, Hee Hwa Ho, Jia Min Chua, Jason Kwok Kong Loh, Fahim Haider Jafary
Publikováno v:
Journal of the American College of Cardiology. 73:S15
Primary percutaneous coronary intervention (PPCI) with new generation drug-eluting stents (DES) is the preferred reperfusion therapy for ST-elevation myocardial infarction (STEMI). For patients with long de novo coronary artery disease, outcomes rema